Laura Palomo-rekin lankidetzan egindako argitalpenak (3)

2021

  1. Analysis of intratumoral heterogeneity in myelodysplastic syndromes with isolated del(5q) using a single cell approach

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. Distinct mutational pattern of myelodysplastic syndromes with and without 5q– treated with lenalidomide

    British Journal of Haematology

2018

  1. Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia

    British Journal of Haematology, Vol. 182, Núm. 3, pp. 373-383